Patient Guide: A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration(nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 50 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04853251
Status: 🟢 Enrolling Now
Condition: Macular Degeneration, Wet Macular Degeneration
Phase: PHASE4

Where You Can Participate

This study is available at 50 locations across the country.

Top locations include:
  • • Mesa, Arizona
  • • Bakersfield, California
  • • Huntington Beach, California
  • • And 47 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration(nAMD) Treated With the Port Delivery System With Ranibizumab (PDS) - Join Clinical Trial NCTNCT04853251

How to Join This Clinical Trial - NCTNCT04853251

Learn how to participate in this PHASE4 trial studying an investigational therapy for Macular Degeneration, Wet Macular Degeneration. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Macular Degeneration, Wet Macular Degeneration. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Macular Degeneration, Wet Macular Degeneration
Treatment Being Tested
Investigational treatment
Study Phase
PHASE4 - Research study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT04853251 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 50 locations. Find a study site near you:

Clinical Research Site

Mesa, Arizona 85206-2747 - United States

Status: RECRUITING

Clinical Research Site

Bakersfield, California 93309 - United States

Status: RECRUITING

Clinical Research Site

Huntington Beach, California 92647 - United States

Status: RECRUITING

Clinical Research Site

Pasadena, California 91107-3747 - United States

Status: RECRUITING

Clinical Research Site

Sacramento, California 95841-2013 - United States

Status: RECRUITING

Clinical Research Site

San Francisco, California 94158-2510 - United States

Status: RECRUITING

Clinical Research Site

Santa Ana, California 92705-6504 - United States

Status: RECRUITING

Clinical Research Site

Torrance, California 90503-3270 - United States

Status: RECRUITING

Clinical Research Site

Durango, Colorado 81303 - United States

Status: COMPLETED

Clinical Research Site

Longmont, Colorado 80503-6499 - United States

Status: RECRUITING

And 40 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE4 clinical trial for Macular Degeneration, Wet Macular Degeneration:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships